{"id":"https://openalex.org/W7204492030","doi":"https://doi.org/10.1128/aac.00808-26","title":"Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin","display_name":"Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin","publication_year":2026,"publication_date":"2026-08-27","ids":{"openalex":"https://openalex.org/W7204492030","doi":"https://doi.org/10.1128/aac.00808-26","pmid":"https://pubmed.ncbi.nlm.nih.gov/42657892"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00808-26","doi":"https://doi.org/10.1128/aac.00808-26","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00808-26","pdf_url":"https://journals.asm.org/doi/pdf/10.1128/aac.00808-26?download=true","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journals.asm.org/doi/pdf/10.1128/aac.00808-26?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055269054","display_name":"Keith A. Rodvold","orcid":"https://orcid.org/0000-0002-7200-7346","observed_orcids":["https://orcid.org/0000-0002-7200-7346"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith A. Rodvold","raw_affiliation_strings":["University of Illinois Chicago"],"raw_orcid":"https://orcid.org/0000-0002-7200-7346","affiliations":[{"raw_affiliation_string":"University of Illinois Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108671077","display_name":"Grigor Mamikonyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grigor Mamikonyan","raw_affiliation_strings":["Clinartis LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinartis LLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148424788","display_name":"Yu Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Wang","raw_affiliation_strings":["Evopoint Biosciences Co Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evopoint Biosciences Co Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122789933","display_name":"Anastasia McRoberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anastasia McRoberts","raw_affiliation_strings":["Pharmaron Germantown"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaron Germantown","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111941724","display_name":"Dyal C. Garg","orcid":"https://orcid.org/0000-0001-7428-3769","observed_orcids":["https://orcid.org/0000-0001-7428-3769"]},"institutions":[{"id":"https://openalex.org/I4210103903","display_name":"Clinical Research Services","ror":"https://ror.org/01c127k53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dyal Garg","raw_affiliation_strings":["Clinical Research Services Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Services Inc","institution_ids":["https://openalex.org/I4210103903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053988717","display_name":"RA Preston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Preston","raw_affiliation_strings":["Division of Clinical Pharmacology, University of Miami"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, University of Miami","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148451734","display_name":"Thomas Marabury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087159","display_name":"Orlando Clinical Research Center","ror":"https://ror.org/000x1tr98","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210087159"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Marabury","raw_affiliation_strings":["Orlando Clinical Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando Clinical Research Center","institution_ids":["https://openalex.org/I4210087159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020498933","display_name":"Meijie Le","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meijie Le","raw_affiliation_strings":["Evopoint Biosciences Co Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evopoint Biosciences Co Ltd","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5138647702","display_name":"Jianguo Li","orcid":"https://orcid.org/0009-0007-7587-5476","observed_orcids":["https://orcid.org/0009-0007-7587-5476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianguo Li","raw_affiliation_strings":["Evopoint Biosceinces USA, Inc"],"raw_orcid":"https://orcid.org/0009-0007-7587-5476","affiliations":[{"raw_affiliation_string":"Evopoint Biosceinces USA, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.69547203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"10","first_page":"e0080826","last_page":"e0080826"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imipenem","display_name":"imipenem","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cilastatin","display_name":"cilastatin","score":1.0},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9869999885559082},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8009999990463257},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.6759999990463257},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.6890000104904175},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.8140000104904175},{"id":"https://openalex.org/keywords/carbapenems","display_name":"carbapenems","score":0.7120000123977661},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.460999995470047},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2777437143","wikidata":"https://www.wikidata.org/wiki/Q418201","display_name":"Cilastatin","level":5,"score":0.8884999752044678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8691999912261963},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.8252999782562256},{"id":"https://openalex.org/C2781255259","wikidata":"https://www.wikidata.org/wiki/Q418201","display_name":"Imipenem/cilastatin","level":5,"score":0.8015000224113464},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.6399999856948853},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6008999943733215},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5999000072479248},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5680999755859375},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5460000038146973},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5108000040054321},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4677000045776367},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.45980000495910645},{"id":"https://openalex.org/C138944611","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Clearance","level":2,"score":0.44179999828338623},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.3801000118255615},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.36090001463890076},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.337799996137619},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3334999978542328},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.29760000109672546},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2833000123500824},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2791999876499176},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.2777999937534332},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.2761000096797943},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.2660999894142151},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.2612999975681305},{"id":"https://openalex.org/C2779541074","wikidata":"https://www.wikidata.org/wiki/Q185643","display_name":"Renal replacement therapy","level":2,"score":0.25870001316070557}],"mesh":[{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.00808-26","doi":"https://doi.org/10.1128/aac.00808-26","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00808-26","pdf_url":"https://journals.asm.org/doi/pdf/10.1128/aac.00808-26?download=true","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:42657892","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42657892","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:doaj.org/article:c591c4c5abee4bcfa0fb5deee4f0e896","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c591c4c5abee4bcfa0fb5deee4f0e896","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial Agents and Chemotherapy, Vol 70, Iss 10 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1128/aac.00808-26","doi":"https://doi.org/10.1128/aac.00808-26","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00808-26","pdf_url":"https://journals.asm.org/doi/pdf/10.1128/aac.00808-26?download=true","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7397875189781189}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324860","display_name":"Pharmaron","ror":"https://ror.org/012qm0r35"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204492030.pdf","grobid_xml":"https://content.openalex.org/works/W7204492030.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W2030363422","https://openalex.org/W2039552192","https://openalex.org/W2055864845","https://openalex.org/W2082009141","https://openalex.org/W2089526947","https://openalex.org/W2092829687","https://openalex.org/W2409049920","https://openalex.org/W2809078834","https://openalex.org/W2995259864","https://openalex.org/W4284975654","https://openalex.org/W4385713076","https://openalex.org/W7164848689"],"related_works":[],"abstract_inverted_index":{"A":[0],"phase":[1],"1,":[2],"open-label":[3],"study":[4,242],"was":[5,207],"conducted":[6],"to":[7,29,85,126,169,219],"investigate":[8],"the":[9,91,102,200],"effect":[10],"of":[11,20,31,60,98,188,224],"renal":[12,36,40,50,89,142,153,235],"impairment":[13,236],"(RI)":[14],"on":[15,35],"pharmacokinetics":[16],"(PK)":[17],"and":[18,27,48,64,75,108,121,136,147,163,180,191,199,227],"safety":[19],"funobactam":[21,61],"plus":[22],"imipenem/cilastatin.":[23],"Participants":[24,56],"were":[25,78],"enrolled":[26],"assigned":[28],"one":[30],"five":[32],"cohorts":[33],"based":[34],"function":[37,154],"category:":[38],"normal":[39,88,152],"function,":[41,90],"mild":[42,114],"RI,":[43,45,47],"moderate":[44],"severe":[46,170,213],"end-stage":[49],"disease":[51],"(ESRD)":[52],"requiring":[53,128,239],"hemodialysis":[54],"(HD).":[55],"received":[57],"a":[58],"single-dose":[59],"with":[62,87,111,196,210,234,245],"imipenem":[63],"cilastatin":[65,109,148,192,228],"by":[66],"intravenous":[67],"infusion":[68],"administered":[69],"over":[70],"60":[71],"min.":[72],"Serial":[73],"blood":[74],"urine":[76],"samples":[77],"collected":[79],"for":[80,105,144],"non-compartmental":[81],"PK":[82],"analysis.":[83],"Compared":[84],"participants":[86],"geometric":[92],"mean":[93],"ratio":[94],"(90%":[95],"confidence":[96],"interval)":[97],"plasma":[99],"area":[100],"under":[101],"curve":[103],"(AUC0-\u221e)":[104],"funobactam,":[106,145,189,225],"imipenem,":[107,146,190,226],"increased":[110],"RI":[112,171],"from":[113,151],"(1.32":[115],"[1.04,":[116,119],"1.66],":[117],"1.37":[118],"1.79],":[120],"1.27":[122],"[0.90,":[123],"1.78],":[124],"respectively)":[125,168],"ESRD":[127,238],"HD":[129],"(9.58":[130],"[7.59,":[131],"12.10],":[132],"2.69":[133],"[2.06,":[134],"3.52],":[135],"15.15":[137],"[10.8,":[138],"21.3],":[139],"respectively).":[140,185],"The":[141,205],"clearance":[143,187,198],"decreased":[149],"progressively":[150],"(3.93":[155],"\u00b1":[156,160,165,173,177,182],"1.12":[157],"L/h,":[158,162,167,175,179,184],"4.95":[159],"2.40":[161],"6.98":[164],"2.75":[166],"(0.94":[172],"0.37":[174],"1.16":[176],"0.34":[178],"1.70":[181],"0.60":[183],"Plasma":[186],"correlated":[193],"(r":[194],"\u22650.93)":[195],"creatinine":[197],"estimated":[201],"glomerular":[202],"filtration":[203],"rate.":[204],"treatment":[206],"well":[208],"tolerated,":[209],"no":[211],"deaths,":[212],"adverse":[214,220],"events,":[215],"or":[216,237],"discontinuation":[217],"due":[218],"events.":[221],"Dosage":[222],"adjustments":[223],"will":[229],"be":[230],"needed":[231],"in":[232],"patients":[233],"HD.CLINICAL":[240],"TRIALSThis":[241],"is":[243],"registered":[244],"ClinicalTrials.gov":[246],"as":[247],"NCT04787562.":[248]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2026-08-28T00:00:00"}